Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other financing activities (2019 - 2025)

Historic Other financing activities for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to -$167000.0.

  • Biodesix's Other financing activities fell 3253.97% to -$167000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$724000.0, marking a year-over-year decrease of 16231.88%. This contributed to the annual value of -$445000.0 for FY2024, which is 15342.14% down from last year.
  • According to the latest figures from Q3 2025, Biodesix's Other financing activities is -$167000.0, which was down 3253.97% from -$190000.0 recorded in Q2 2025.
  • Biodesix's Other financing activities' 5-year high stood at $2.1 million during Q2 2022, with a 5-year trough of -$198000.0 in Q1 2025.
  • Over the past 5 years, Biodesix's median Other financing activities value was $1000.0 (recorded in 2021), while the average stood at $234555.6.
  • Its Other financing activities has fluctuated over the past 5 years, first surged by 20840000.0% in 2022, then crashed by 1270000.0% in 2024.
  • Biodesix's Other financing activities (Quarter) stood at $568000.0 in 2021, then surged by 159.86% to $1.5 million in 2022, then tumbled by 99.93% to $1000.0 in 2023, then plummeted by 17000.0% to -$169000.0 in 2024, then increased by 1.18% to -$167000.0 in 2025.
  • Its Other financing activities stands at -$167000.0 for Q3 2025, versus -$190000.0 for Q2 2025 and -$198000.0 for Q1 2025.